FDA clears Caristo’s AI-powered CAD diagnostic software
The US Food and Drug Administration (FDA) has given the greenlight to Caristo Diagnostics for CaRi-Plaque, an artificial intelligence (AI)-assisted software application that diagnoses coronary artery disease (CAD). The post FDA clears Caristo’s AI-powered CAD diagnostic software appeared first on Medical Device Network.
The US Food and Drug Administration (FDA) has given the greenlight to Caristo Diagnostics for CaRi-Plaque, an artificial intelligence (AI)-assisted software application that diagnoses coronary artery disease (CAD).
The post FDA clears Caristo’s AI-powered CAD diagnostic software appeared first on Medical Device Network.
